References
1. Then E.O., Lopez M., Saleem S., Gayam V., Sunkara T., Culliford A., et al. Esophageal cancer: an updated surveillance epidemiology and end results database analysis. World J Oncol. 2020; 11 (2): 55–64. DOI: https://doi.org/10.14740/wjon1254
2. Strong V.E., Song K.Y., Park C.H., Jacks L.M., Gonen M., et al. Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram. Ann Surg. 2010; 251: 640–6. DOI: https://doi.org/10.1097/SLA.0b013e3181d3d29b
3. Cellini F., Morganti A.G., Di Matteo F.M., Mattiucci G.C., Valentini V. Clinical management of gastroesophageal junction tumors: past and recent evidences for the role of radiotherapy in the multidisciplinary approach. Radiat Oncol. 2014; 9: 45. DOI: https://doi.org/10.1186/1748-717X-9-45
4. Ellis F.H., Gibb S.P., Watkins E. Limited esophagogastrectomy for carcinoma of the cardia: indications, technique and results. Ann Surg. 1988; 208 (3): 354–61. DOI: https://doi.org/10.1097/00000658-198809000-00013
5. Dolan K., Sutton R., Walker S.J., Morris A.I., Campbell F., Williams E.M. New classification of oesophageal and gastric carcinomas derived from changing patterns in epidemiology. Br J Cancer. 1999; 80 (5–6): 834–42. DOI: https://doi.org/10.1038/sj.bjc.6690429
6. Oo A.M., Ahmed S. Overview of gastroesophageal junction cancers. Mini-Invasive Surg. 2019; 3: 13. DOI: https://doi.org/10.20517/2574-1225.2019.02
7. Ekström A.M., Signorello L.B., Hansson L.E., Bergström R., Lindgren A., et al. Evaluating gastric cancer misclassification: a potential explanation for the rise in cardia cancer incidence. J Natl Cancer Inst. 1999; 91: 786–90.
8. Chernousov A.F., Khorobrykh T.V., Vychuzhanin D.V. Results of surgical treatment of patients with cardioesophageal cancer // Sechenovskiy vestnik. 2010; (1): 36–40. (in Russian)
9. Tikaev E.R., Burmistrov M.V., Enikeev R.F., Zinchen- ko S.V., Sigal E.I. et al. Modern approaches to the surgical treatment of cardia cancer with transition to the esophagus. Siberian Journal of Oncology. 2011; 1 (43): 61–5. (in Russian)
10. Rice T.W., Kelsen D.P., Blackstone E.H., et al. Esophagus and esophagogastric junction. In: M.B. Amin, S.B. Edge, F.L. Greene, et al. (eds). AJCC Cancer Staging Manual. 8th ed. New York: Springer, 2017: 185–202.
11. Siewert J.R., Stein H.J. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg. 1998; 85 (11): 1457–9. DOI: https://doi.org/10.1046/j.1365-2168.1998.0 0940.x
12. Misumi A., Murakami A., Harada K., Baba K., Akagi M. Definition of carcinoma of the gastric cardia. Langenbecks Arch Chir. 1989; 374 (4): 221–6. DOI: https://doi.org/10.1007/BF01359557
13. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma: 3rd English edition. Gastric Cancer. 2011; 14 (2): 101–12. DO: https://doi.org/10.1007/s10120-011-0041-5
14. Japan Esophageal Society. Japanese Classification of Esophageal Cancer. 10th edition: part I. Esophagus. 2009(a); 6 (1): 1–25. DOI: https://doi.org/10.1007/s10388-009-0169-0
15. Japan Esophageal Society. Japanese Classification of Esophageal Cancer. 10th edition: parts II and III. Esophagus. 2009(b); 6(2): 71–94. DOI: https://doi.org/10.1007/s10388-009-0193-0
16. Hölscher A.H., Law S. Esophagogastric junction adenocarcinomas: individualization of resection with special considerations for Siewert type II, and Nishi types EG, E=G and GE cancers. Gastric Cancer. 2020; 23 (1): 3–9. DOI: https://doi.org/10.1007/s10120-019-01022-x
17. Li C.L., Zhang F.L., Wang Y.D., Han C., Sun G.G., Liu Q., et al. Characteristics of recurrence after radical esophagectomy with two-field lymph node dissection for thoracic esophageal cancer. Oncol Lett. 2013; 5 (1): 355–9. DOI: https://doi.org/10.3892/ol.2012.946
18. Shah S.V., Chheda Y.P., Pillai S.K., Shah S.V. Total oesophagectomy for squamous cell carcinoma with or without standard two field node dissection – a prospective study. Indian J Surg Oncol. 2013; 4 (4): 336–40. DOI: https://doi.org/10.1007/s13193-013-0264-5
19. Vijayakumar M., Burrah R., Hari K., Veerendra K.V., Krishnamurthy S. Esophagectomy for cancer of the esophagus. A regional cancer centre experience. Indian J Surg Oncol. 2013; 4 (4): 332–5. DOI: https://doi.org/10.1007/s13193-013- 0260-9
20. Grotenhuis B.A., Wijnhoven B.P., van Marion R., van Dekken H., Hop W.C., Tilanus H.W., et al. The sentinel node concept in adenocarcinomas of the distal esophagus and gastroesophageal junction. J Thorac Cardiovasc Surg. 2009; 138 (3): 608–12. DOI: https://doi.org/10.1016/j.jtcvs.2008.11. 061
21. Rüdiger Siewert J., Feith M., Werner M., Stein H.J. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg. 2000; 232 (3): 353–61. DOI: https://doi.org/10.1097/00000658-200009000-00007
22. International Union against Cancer. TNM Classification of Malignant Tumours. 7th ed. In: L.H. Sobin, M.K. Gospodarowicz, Ch. Wittekind (eds). New York: John Wiley & Sons, 2009: 310 p.
23. Edge S.B, Compton C.C. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010; 17 (6): 1471–4. DOI: https://doi.org/10.1245/s10434-010-0985-4
24. Siewert J.R., Stein H.J., Feith M. Adenocarcinoma of the esophago-gastric junction. Scand J Surg. 2006; 95 (4): 260–9. DOI: https://doi.org/10.1177/145749690609500409
25. Matsuda T., Takeuchi H., Tsuwano S., Nakamura R., Takahashi T., Wada N., et al. Optimal surgical management for esophagogastric junction carcinoma. Gen Thorac Cardiovasc Surg. 2014; 62 (9): 560–6. DOI: https://doi.org/10.1007/s11748-014- 0381-2
26. Pedrazzani C., de Manzoni G., Marrelli D., Giacopuzzi S., Corso G., Minicozzi A.M., et al. Lymph node involvement in advanced gastroesophageal junction adenocarcinoma. J Thorac Cardiovasc Surg. 2007; 134 (2): 378–85. DOI: https://doi.org/10.1016/j.jtcvs.2007.03.034
27. Davydov M.I., Turkin I.N., Stilidi I.S., Polotsky B.E., Ter-Ovanesov M.D. Cardioesophageal cancer: classification, surgical tactics, main prognostic factors. Bulletin of N.N. Blokhin RAMS. 2003; (1): 82–9. (in Russian)
28. Berdov B.A., Mardynsky Yu.S., Skoropad V.Yu. Long-term results of a clinical study of the effectiveness of pre- and intraoperative radiation therapy in the combined treatment of gastric cancer // Issues of Oncology. 2006; (5): 515–20. (in Russian)
29. Vrouenraets B.C., van Lanschot J.J. Extent of surgical resection for esophageal and gastroesophageal junction adenocarcinomas. Surg Oncol Clin N Am. 2006; 15 (4): 781–91. DOI: https://doi.org/10.1016/j.soc.2006.07.008
30. Birkmeyer J.D., Sun Y., Wong S.L., Stukel T.A. Hospital volume and late survival after cancer surgery. Ann Surg. 2007; 245 (5): 777–83. DOI: https://doi.org/10.1097/01.sla.0000252402.33814.dd
31. Lerut T., Moons J., Coosemans W., Decaluwé H., Dec- ker G., De Leyn P., et al. Multidisciplinary treatment of advanced cancer of the esophagus and gastroesophageal junction: a European center’s approach. Surg Oncol Clin N Am. 2008; 17 (3): 485–502, vii–viii. DOI: https://doi.org/10.1016/j.soc.2008. 02.007
32. Rindani R., Martin C.J., Cox M.R. Transhiatal versus Ivor-Lewis oesophagectomy: is there a difference? Aust N Z J Surg. 1999; 69 (3): 187–94. DOI: https://doi.org/10.1046/j.1440-1622.1999.01520.x
33. Enzinger P.C., Mayer R.J. Esophageal cancer. N Engl J Med. 2003; 349 (23): 2241–52. DOI: https://doi.org/10.1056/NEJMra035010
34. Chang A.C., Ji H., Birkmeyer N.J., Orringer M.B., Birkmeyer J.D. Outcomes after transhiatal and transthoracic esophagectomy for cancer. Ann Thorac Surg. 2008; 85 (2): 424–9. DOI: https://doi.org/10.1016/j.athoracsur.2007.10.007